You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Isa-KRD

Showing 1 - 25 of 99
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (Carfilzomib Lenalidomide Dexamethasone, Isatuximab Carfilzomib Lenalidomide Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib Lenalidomide Dexamethasone
  • Isatuximab Carfilzomib Lenalidomide Dexamethasone
  • Ostrava, Czechia
  • +6 more
Jul 26, 2022

Multiple Myeloma Trial in France (Isatuximab, ASCT)

Recruiting
  • Multiple Myeloma
  • AMIENS Cedex 1, France
  • +67 more
Mar 28, 2022

Newly Diagnosed Multiple Myeloma Trial in Spain (Bortezomib, Isatuximab, Iberdomide)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Alcalá de Henares, Madrid, Spain
  • +67 more
Sep 23, 2022

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Carfilzomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Fountain Valley, California
  • +107 more
Dec 7, 2022

Long-term KRd in Relapsed and/or Refractory Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Aug 8, 2022

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023

Multiple Myeloma Trial in Sweden, United States (Bortezomib, Dexamethasone, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Miami, Florida
  • +8 more
Nov 23, 2021

Multiple Myeloma Trial in Seoul (Lenalidomide maintenance)

Recruiting
  • Multiple Myeloma
  • Lenalidomide maintenance
  • Seoul, Korea, Republic of
    Samsung Medical Center
Aug 10, 2022

Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

Recruiting
  • Medulloblastoma
  • +7 more
  • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
  • +2 more
  • Buffalo, New York
  • +2 more
Jul 8, 2022

Multiple Myeloma, New Diagnosis Tumor Trial in Italy (Carfilzomib, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • New Diagnosis Tumor
  • Alessandria, Italy
  • +41 more
Mar 24, 2022

Sudden Infant Death, Sudden Unexplained Infant Death Trial (ISA-MI, Standard of Care (SOC))

Not yet recruiting
  • Sudden Infant Death
  • Sudden Unexplained Infant Death
  • ISA-MI
  • Standard of Care (SOC)
  • (no location specified)
Aug 12, 2022

Multiple Myeloma, Relapse, Refractory Trial in Chapel Hill, Winston-Salem, Columbus (Isatuximab, Pomalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +4 more
  • Chapel Hill, North Carolina
  • +2 more
Jun 9, 2023

Newly Diagnosed Multiple Myeloma Trial in Austria, Germany (Elotuzumab, Carfilzomib, Lenalidomide)

Active, not recruiting
  • Newly Diagnosed Multiple Myeloma
  • Krems, Lower Austria, Austria
  • +55 more
Jan 4, 2022

Myeloma, Multiple Myeloma Trial in Chicago (Daratumumab, Carfilzomib, Lenalidomide)

Recruiting
  • Myeloma
  • Multiple Myeloma
  • Chicago, Illinois
    The University of Chicago
Sep 15, 2021

Painful Diabetic Neuropathy Trial (NRD135SE.1, Placebo)

Not yet recruiting
  • Painful Diabetic Neuropathy
  • (no location specified)
Aug 15, 2022

Multiple Myeloma Trial in Austria, Germany (Carfilzomib, Thalidomide, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Graz, Austria
  • +20 more
Jan 18, 2022

Myeloma Trial in Denmark, Norway, Sweden (Carfilzomib, Lenalidomide, PET-CT)

Recruiting
  • Myeloma
  • Copenhagen, Denmark
  • +3 more
Sep 15, 2021

Glioblastoma Multiforme of Brain Trial in Tübingen (Multipeptide plus XS15)

Recruiting
  • Glioblastoma Multiforme of Brain
  • Multipeptide plus XS15
  • Tübingen, BW, Germany
    University Hospital Tübingen
May 9, 2022

Crohn Disease Trial (Mirikizumab)

Not yet recruiting
  • Crohn Disease
  • (no location specified)
Aug 19, 2022

Smouldering Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone, Lenalidomide)

Recruiting
  • Smouldering Myeloma
  • Brno, Czechia
  • +15 more
Mar 22, 2022

Multiple Myeloma Trial in Denmark, Ireland (Isatuximab, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Aarhus, Denmark
  • +5 more
Jul 29, 2022

Multiple Myeloma Trial in Chicago (Carfilzomib, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
Jun 7, 2021

Duchenne Muscular Dystrophy, Spinal Muscular Atrophy Trial (Alert "AFNOR 3.6"., Alertes " AFNOR 3.6 " et alertes " Guidelines

Recruiting
  • Duchenne Muscular Dystrophy
  • Spinal Muscular Atrophy
  • Alert "AFNOR 3.6".
  • Alertes " AFNOR 3.6 " et alertes " Guidelines ".
  • Garches, France
    Hôpital Raymond Poincaré
Oct 11, 2022

Depression Trial in Zürich (Cognitive Behavioural Therapy (CBT), Ecological Momentary Assessment (EMA))

Not yet recruiting
  • Depression
  • Cognitive Behavioural Therapy (CBT)
  • Ecological Momentary Assessment (EMA)
  • Zürich, Kanton Zürich, Switzerland
    Psychotherapeutisches Zentrum Universität Zürich
Sep 22, 2022

Yellow Fever, Yellow Fever Immunisation Trial in Iowa City, Saint Louis (drug, biological, other)

Completed
  • Yellow Fever
  • Yellow Fever Immunisation
  • Iowa City, Iowa
  • +1 more
Jun 24, 2021